Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Postoperative Organ Injury, Risk Factors, and Short-Term Clinical Outcomes in Patients Admitted to Intensive Care After Noncardiac Surgery

NCT07907887 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07907887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Postoperative Organ Injury, Risk Factors, and Short-Term Clinical Outcomes in Patients Admitted to Intensive Care After Noncardiac Surgery
Lead sponsor
Ankara Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
September 30, 2026
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • Noncardiac Surgery ICU Cohort

    Patients admitted to intensive care after emergency or elective noncardiac surgery who had preoperative troponin measurements and postoperative kidney function data available in their medical records. This retrospective cohort includes 224 patients. Patients with chronic kidney disease are included. No intervention was assigned as part of the study.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Acute Kidney Injury Within 48 Hours After Surgery From completion of surgery through 48 hours postoperatively.

    Occurrence of acute kidney injury, defined by an increase in serum creatinine of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times the preoperative baseline within the observed 48-hour period, or initiation of renal replacement therapy. Assessment uses the serum creatinine and renal replacement therapy components of KDIGO criteria. Urine output criteria are not used because reliable retrospective data are unavailable.

Lead sponsor's other trials

Ankara Training and Research Hospital, most recent start first.

Similar trials

Same condition (Acute Kidney Injury) and phase, most recent start first.